
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
We are seeking a Director / Senior Director, Quality Control Automation and Digitalization to lead the strategic transformation of Quality Control operations through advanced automation and digital platforms. This role blends strategic leadership with deep hands-on technical expertise in laboratory automation, digital solutions, and GMP operations. The position will serve as the QC Automation Lead, responsible for overseeing and coordinating end‑to‑end automated analytical workflows across multiple functions, including Analytical Development, Automation, Computational Biology, Quality Control, Quality Assurance, Information Technology, and Validation. This leader will drive cross‑functional alignment to ensure streamlined processes and timely delivery of robust, compliant analytical methods and procedures in support of GMP testing. In addition, this role is accountable for implementing comprehensive training programs to strengthen QC capabilities in automated and digital platforms, ensuring scientific rigor, data integrity, and operational excellence. The Senior Director/Director will foster a culture of innovation and continuous improvement, positioning QC to support current and future portfolio and regulatory needs.
Primary Responsibilities:
Qualifications:
The salary range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on several factors including, but not limited to, relevant experience, education, scope of job, internal comparisons, and market data.
Beam Pay Range $210,000—$320,000 USD

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.
Our dream is to provide life-long cures for patients suffering from serious diseases.
The Beam Team Is:
• A community of fearless innovators
• Rigorous and honest in our research
• Listening with open minds
• Committed to each other